Clinical trialNCT00750139CompletedPhase 3Interventional

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis

SponsorMerz North America, Inc.Enrollment707Athlete's FootTinea Pedis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo, when used in subjects with tinea pedis (athlete's foot).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lawrence Parish, MD
Paddington Testing Company
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Radiant Research
Birmingham, Alabama, United States
Dr. Felix Sigal
Los Angeles, California, United States
University of California San Francisco, Dept of Dermatology
San Francisco, California, United States
Fxm Research
Miami, Florida, United States
Fxm Research
Miramar, Florida, United States
Glazer Dermatology
Buffalo Grove, Illinois, United States
Tulane University Health Services
New Orleans, Louisiana, United States
Silverton Skin Institute
Grand Blanc, Michigan, United States
Zoe Draelos, Md
High Point, North Carolina, United States
Haber Dermatology
Euclid, Ohio, United States
Oregon Dermatology and Research Center
Portland, Oregon, United States
Paddington Testing Company
Philadelphia, Pennsylvania, United States
Temple University School of Podiatric Medicine
Philadelphia, Pennsylvania, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
J & S Studies
College Station, Texas, United States
Research Across America
Dallas, Texas, United States
Research Across America
Plano, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NAFT-500Naftin 1%Placebo 2-weeksPlacebo 4-weeks

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2008
Primary completion: 31 Aug 2009
Completion: 31 Dec 2009
Last update posted: 26 Apr 2013
Registered enrollment: 707
Registry id: NCT00750139

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.